Host kinin B1 receptor plays a protective role against melanoma progression

Area of Science:

• Oncology
• Immunology
• Biochemistry

Background:

• Melanoma is an aggressive cancer with limited treatment options for advanced stages.
• The kallikrein-kinin system (KKS) is involved in various physiological processes, but its role in melanoma is unclear.
• Understanding KKS involvement could reveal new therapeutic targets for melanoma.

Purpose of the Study:

• To investigate the role of the host kinin B1 receptor in melanoma development and progression.
• To evaluate the impact of B1 receptor deficiency on primary tumor growth and metastasis.
• To assess the host immune response in the context of B1 receptor activity during melanoma.

Main Methods:

• A syngeneic melanoma model using B16F10 cells in wild-type (WT) and B1 receptor knockout (B1(-/-)) C57BL/6 mice.
• Subcutaneous injection for primary tumor studies and tail vein injection for metastasis studies.
• Analysis of tumor characteristics, immune cell populations, and molecular signaling pathways.

Main Results:

• B1(-/-) mice developed primary tumors with increased ulceration, higher IL-10 levels, and enhanced activation of proliferative pathways (ERK1/2, Akt).
• B1(-/-) mice exhibited a higher mitotic index in primary tumors.
• In the metastasis model, B1(-/-) mice showed larger lung colonies and reduced CD8(+) immune effector cells compared to WT mice.

Conclusions:

• B1 receptor deficiency is associated with features of poor prognosis in primary melanoma.
• The absence of the B1 receptor promotes an unfavorable metastatic onset.
• The B1 receptor appears to play a protective role in the host's response against melanoma progression, suggesting it as a potential therapeutic target.